AR117942A1 - VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM - Google Patents

VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM

Info

Publication number
AR117942A1
AR117942A1 ARP180103216A ARP180103216A AR117942A1 AR 117942 A1 AR117942 A1 AR 117942A1 AR P180103216 A ARP180103216 A AR P180103216A AR P180103216 A ARP180103216 A AR P180103216A AR 117942 A1 AR117942 A1 AR 117942A1
Authority
AR
Argentina
Prior art keywords
methods
immunogenic compositions
vaccines against
against zika
zika
Prior art date
Application number
ARP180103216A
Other languages
Spanish (es)
Inventor
Sushma Kommareddy
Hetal Patel
Moerlooze Laurence De
Gary Dubin
Jackie Marks
Raman Rao
Htay Htay Han
Hansi Dean
Jill A Livengood
Original Assignee
Takeda Vaccines Inc
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc, Us Health filed Critical Takeda Vaccines Inc
Publication of AR117942A1 publication Critical patent/AR117942A1/en

Links

Abstract

Vacunas contra el virus de Zika y composiciones inmunogénicas que tienen uno o más antígenos de un virus de Zika (por ejemplo, una forma aislada clonal del virus de Zika, un virus de Zica adaptado a células no humanas, etc.), y métodos de tratamiento y usos de las mismas.Zika virus vaccines and immunogenic compositions that have one or more antigens of a Zika virus (e.g., a clonal isolated form of Zika virus, a Zica virus adapted to non-human cells, etc.), and methods of treatment and uses thereof.

ARP180103216A 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM AR117942A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762581500P 2017-11-03 2017-11-03

Publications (1)

Publication Number Publication Date
AR117942A1 true AR117942A1 (en) 2021-09-08

Family

ID=71523240

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP180103214A AR113832A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM
ARP180103213A AR113831A1 (en) 2017-11-03 2018-11-05 METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION
ARP180103216A AR117942A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP180103214A AR113832A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM
ARP180103213A AR113831A1 (en) 2017-11-03 2018-11-05 METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION

Country Status (1)

Country Link
AR (3) AR113832A1 (en)

Also Published As

Publication number Publication date
AR113832A1 (en) 2020-06-17
AR113831A1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
MX2020004543A (en) Zika vaccines and immunogenic compositions, and methods of using the same.
MX2018007627A (en) Zika virus vaccine.
CO2018001534A2 (en) An arboviral vaccine composition
CL2017000987A1 (en) CMV modified virus type particles
CL2017003151A1 (en) Formulations for vaccines against neoplasia and methods to prepare them
UY37252A (en) COMPOUNDS FOR HEPATITIS B VIRUS INFECTION TREATMENT
BR112017001310A2 (en) coronavirus
MX2017001406A (en) Flagellin-based agents and uses including effective vaccination.
CL2019003805A1 (en) Senecavirus a Immunogenic Compositions and Methods of These.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR102547A1 (en) VACCINES AGAINST DISEASE OF HANDS, FEET AND MOUTH AND MANUFACTURING METHODS AND THEIR USE
UY32457A (en) VACCINE OF THE INACTIVATED DENGUE VIRUS
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
CO2018010874A2 (en) Live attenuated Zika virus vaccine
CL2016002402A1 (en) Immunological compositions containing histophilus somni attenuated
BR112017003462A2 (en) attenuated bovine coronavirus, vaccine, and method of vaccination of a bovine.
MX2020005554A (en) Zika vaccines and immunogenic compositions, and methods of using the same.
MX2017005687A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus.
PE20190397A1 (en) DUCK ENTERITIS VIRUS AND USES OF IT
EA201691638A1 (en) NEW WAYS OF INDUCING IMMUNE RESPONSE
BR112018074910A2 (en) immunological composition, and method of inducing an immune response against equine influenza virus in a subject
CO2018010359A2 (en) Constraints of live attenuated alphavirus and methods and uses thereof
CL2016001906A1 (en) Vaccines against avian reovirus.
PE20190225A1 (en) A METHOD TO REDUCE EGG CONTAMINATION
EA201790771A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FOR THE TREATMENT OF HEPATITIS C